Advertisement

Newer Hypolipidemic Compounds

  • David Kritchevsky
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 63)

Abstract

The inhibition of lipidemia can be achieved in several ways. The most logical mechanism — interference with lipoprotein metabolism (synthesis, release or catabolism) — has not been approached in a rational manner. There are some effective hypolipidemic drugs but their mechanisms of action are not clear and the search for a more effective compound continues.

Keywords

Serum Cholesterol Serum Cholesterol Level Isobutyric Acid Lower Serum Cholesterol Reduce Serum Cholesterol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kritchevsky, D. Lipids 9:97, 1974.CrossRefGoogle Scholar
  2. 2.
    Craig, G. M. and K. W. Walton. Atherosclerosis 15: 189, 1972.PubMedCrossRefGoogle Scholar
  3. 3.
    Granzer, E. and H. Nahm. Arzneimittel-Forschung 23: 1353, 1973.PubMedGoogle Scholar
  4. 4.
    Imai, Y. and K. Shimamoto. Atherosclerosis 17: 121, 1973.PubMedCrossRefGoogle Scholar
  5. 5.
    Kritchevsky, D. and S. A. Tepper. Atherosclerosis 18: 93, 1973.PubMedCrossRefGoogle Scholar
  6. 6.
    Toki, K., Y. Nakamura, K. Agatsuma, H. Nakatani and S. Aono. Atherosclerosis 18: 101, 1973.PubMedCrossRefGoogle Scholar
  7. 7.
    Gilfillan, J. L., V. M. Hunt and J. W. Huff. Proc. Soc. Exp. Biol. Med. 136: 1274, 1971.PubMedGoogle Scholar
  8. 8.
    Kritchevsky, D. and S. A. Tepper. Proc. Soc. Exp. Biol. Med. 139: 1284, 1972.PubMedGoogle Scholar
  9. 9.
    Aronow, W. S., J. S. Vangrow, W. H. Nelson, J. Pagano, N. P. Papageorge’s, M. Khursheed, P. R. Harding and M. Khemka. Current Therapeutic Res. 15: 902, 1973.Google Scholar
  10. 10.
    Barnhart, J. W., J. A. Sefranka and D. D. Mcintosh. Am. J. Clin. Nutrition 23: 1229, 1970.Google Scholar
  11. 11.
    Kritchevsky, D. Fed. Proc. 30:835, 1971.PubMedGoogle Scholar
  12. 12.
    Kritchevsky, D., H. K. Kim and S. A. Tepper. Proc. Soc. Exp. Biol. Med. 136: 1216, 1971.PubMedGoogle Scholar
  13. 13.
    Miettinen, T. A. Atherosclerosis 15: 163, 1972.PubMedCrossRefGoogle Scholar
  14. 14.
    Polachek, A. A., H. M. Katz, J. Sack, J. Selig and M. L. Littman. Current Med. Res. and Opinion 1: 323, 1973.CrossRefGoogle Scholar
  15. 15.
    Harris, R. J., Jr., H. R. Gilmore III, L. A. Bricker, I. M. Kiem and E. Rubin. J. Am. Geriatric Soc. 22: 167, 1974.Google Scholar
  16. 16.
    Renzi, A.A., D.J. Rytter, E. R. Wagner and H. K. Goersch. Abstracts 5th Symposium on Drugs Affecting Lipid Metabolism, p. 87, 1974.Google Scholar
  17. 17.
    Assous, E., M. Pouget, J. Nadaud, G. Tartary, M. Henry J. Duteil. Therapie 27: 395, 1972.PubMedGoogle Scholar
  18. 18.
    Rouffy, J. and J. Loeper. Therapie 27: 433, 1972.PubMedGoogle Scholar
  19. 19.
    Martin, E. and G. Feldmann, Path-Biol. 22: 179, 1974.Google Scholar
  20. 20.
    Santilli, A. A., A. C. Scotese and R. M. Tomarelli. Experientia, in press.Google Scholar
  21. 21.
    Pereira, J.N. and G. F. Holland. Abstracts 5th Symposium on Drugs Affecting Lipid Metabolism, p. 83, 1974.Google Scholar
  22. 22.
    Buchanan, R. L. and V. Sprancmanis. J. Med. Chem. 16: 174, 1973.PubMedCrossRefGoogle Scholar
  23. 23.
    Kaneda, T. and S. Tokuda. J. Nutrition 90: 371, 1966.Google Scholar
  24. 24.
    Chibata, I., K. Okumura, S. Takeyama and K. Kotera. Experientia 25: 1237, 1969.PubMedCrossRefGoogle Scholar
  25. 25.
    Kamiya, T., Y. Saito, M. Hashimoto and H. Seki. Tetra-hedon Letters 53: 4729, 1969.CrossRefGoogle Scholar
  26. 26.
    Takashima, K., K. Izumi, H. Iwai and S. Takeyama. Atherosclerosis 17: 491, 1973.PubMedCrossRefGoogle Scholar
  27. 27.
    Takashima, K., C. Sato, Y. Sasaki, T. Morita and S. Takeyama. Biochem. Pharmacol. 23: 433, 1974.PubMedCrossRefGoogle Scholar
  28. 28.
    Hashim, S.A. and T. B. Van It allie. J. Am. Med. Assoc. 192: 289, 1965.CrossRefGoogle Scholar
  29. 29.
    Fallon, H.J. and J. W. Woods. J. Am. Med. Assoc. 204: 1161, 1968.CrossRefGoogle Scholar
  30. 30.
    Nazir, D. J., L. Horlick, B. J. Kudchodkar and H. S. Sodhi. Circulation 46: 95, 1972.PubMedGoogle Scholar
  31. 31.
    Parkinson, T. M., K. Gundersen and N. A. Nelson. Atherosclerosis 11: 531, 1970.PubMedCrossRefGoogle Scholar
  32. 32.
    Parkinson, T. M., J. C. Schneider, Jr. and W. A. Phillips. Atherosclerosis 17: 167, 1973.PubMedCrossRefGoogle Scholar
  33. 33.
    Kritchevsky, D., H. K. Kim and S. A. Tepper. Proc. Soc. Exp. Biol. Med. 142: 185, 1973.PubMedGoogle Scholar
  34. 34.
    Ryan, J. R. and A. Jain. J. Clin. Pharmacol. 12:268, 1972.Google Scholar
  35. 35.
    Nye, E. R., D. Jackson and J. D. Hunter. New Zealand Med. J. 76: 12, 1972.PubMedGoogle Scholar
  36. 36.
    Sachs, B. A. and L. Wolfman. N. Y. State J. Med. 73: 1068, 1973.PubMedGoogle Scholar
  37. 37.
    Gross, L. and R. Figueredo. J. Am. Geriatrics Soc. 21: 552, 1973.Google Scholar
  38. 38.
    N. E. Miller, P. Clifton-Bligh and P. J. Nestel. J. Lab. Clin. Med. 82: 876, 1973.PubMedGoogle Scholar
  39. 39.
    Goodman, D. S., R. P. Noble and R. B. Dell. J. Clin, Invest. 52: 2646, 1973.CrossRefGoogle Scholar
  40. 40.
    Glueck, C. J., S. Ford, Jr., D. Scheel and P. Steiner. J. Am. Med. Assoc. 222: 676, 1972.CrossRefGoogle Scholar
  41. 41.
    Evans, R. J. C., A. N. Howard and D. E. Hyams. Angiology 24: 22, 1973.PubMedCrossRefGoogle Scholar
  42. 42.
    Howard, A.N. and R. J. C. Evans. Atherosclerosis 20: 105, 1974.PubMedCrossRefGoogle Scholar
  43. 43.
    Itokawa, Y., K. Inoue, S. Sasagawa and M. Fujiwara. J. Nutrition 103: 88, 1973.Google Scholar
  44. 44.
    Mitschek, G. H. A. Quart. J. Crude Drug Res. 10:1550, 1970.Google Scholar

Copyright information

© Plenum Press, New York 1975

Authors and Affiliations

  • David Kritchevsky
    • 1
  1. 1.The Wistar Institute of Anatomy and BiologyPhiladelphiaUSA

Personalised recommendations